triazoles has been researched along with Cystic Fibrosis in 53 studies
*Cystic Fibrosis: An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION. [MeSH]
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 12 (22.64) | 29.6817 |
2010's | 33 (62.26) | 24.3611 |
2020's | 8 (15.09) | 2.80 |
Authors | Studies |
---|---|
Bentley, S; Davies, JC; Donovan, J; Gastine, S; Standing, JF | 1 |
Amaral, MD; Bacalhau, M; Buarque, CD; da Silva, VD; Ferreira, FC; Kmit, A; Lopes-Pacheco, M; Pimentel, AS; Souza, FR | 1 |
Brito Devoto, T; Cuestas, ML; Finquelievich, JL; García-Effrón, G; Hermida-Alva, K; Posse, G | 2 |
Balfour-Lynn, IM; Bentley, S; Carr, SB; Davies, JC | 1 |
Aller, SG; Bacsa, J; Breton, GW; Doiron, JE; Le, CA; Martin, KL; Turlington, M | 1 |
Al-Obaidi, M; Badali, H; Cañete-Gibas, C; Patterson, HP; Wiederhold, NP | 1 |
Hanretty, AM; Langelier, C; Trang, TP; Yang, K | 1 |
Cases Viedma, E; García-Robles, AA; Jordá, C; Mancheño, N; Pemán, J; Poveda-Andrés, JL; Reig Mezquida, JP; Solé, A | 1 |
Armstrong-James, DPH; Eades, CP; Jones, A; Kelleher, P; Periselneris, J; Shah, A; Simmonds, N | 1 |
Kabulski, GM; MacVane, SH | 1 |
Abdolrasouli, A; Armstrong-James, D; Elborn, JS; Fisher, MC; Rhodes, J; Schelenz, S; Scourfield, A; Shah, A | 1 |
Armstrong-James, D; Nwankwo, L; Periselneris, J; Schelenz, S; Shah, A | 1 |
Claydon, A; Gaillard, EA; Modha, DE; Patel, D; Popple, S | 1 |
Baldelli, S; Cattaneo, D; Clementi, E; Colombo, C; Cozzi, V; Faelli, NML; Fusi, M; Russo, M | 1 |
Kirikou, H; Loukou, I; Moustaki, M; Petrocheilou, A; Stathi, A; Velegraki, A; Zachariadou, L | 1 |
Amin, A; Hussain, R; Johannesson, M; Oliynyk, I; Roomans, GM | 1 |
Chen, SC; Meyer, W; Middleton, PG | 1 |
Clements, RM; Estrada, L; Jon, CK; Mosquera, RA | 1 |
Moss, RB | 1 |
Clancy, CJ; Ensor, C; Joshi, R; Nguyen, MH; Shields, RK; Venkataramanan, R; Zhang, H; Zhao, W | 1 |
Augustynowicz-Kopeć, E; Garczewska, B; Jarzynka, S; Kuś, J; Skorupa, W | 1 |
Clifford, RL; Knox, AJ; Patel, JK; Poghosyan, A | 1 |
Barao Ocampo, M; Biffi, A; Colombo, C; De Lorenzis, G; Esposto, MC; Favuzzi, V; Koncan, R; Lo Cascio, G; Pizzamiglio, G; Prigitano, A; Romanò, L; Tortorano, AM | 1 |
Moreau-Marquis, S; O'Toole, GA; Stanton, BA | 1 |
Elnazir, B; Glackin, L; Greally, P; Leen, G | 1 |
Amrein, C; Batisse, A; Berge, M; Billaud, EM; Boussaud, V; Chevalier, P; Dannaoui, E; Guillemain, R; Lillo-Le Louet, A; Loriot, MA; Pham, MH | 1 |
Amrein, C; Benammar, M; Berge, M; Billaud, EM; Boussaud, V; Chevalier, P; Guillemain, R; Lefeuvre, S | 1 |
Fothergill, AW; Hickey, PW; Rinaldi, MG; Schmidt, HJ; Sutton, DA; Walsh, TJ; Wickes, BL | 1 |
Begué, D; Billaud, E; Boussaud, V; Caruba, T; Guillemain, R; Korb, V; Prognon, P; Sabatier, B; Thomas, A | 1 |
Bouchara, JP; Danner-Boucher, I; Despins, P; Gay-Andrieu, F; Haloun, A; Horeau-Langlard, D; Jossic, F; Le Pape, P; Miegeville, M; Morio, F; Nourry, L; Pattier, S; Talarmin, JP; Treilhaud, M | 1 |
Cooperstock, MS; Griffard, EA; Guajardo, JR; Scoville, CL | 1 |
Cheng, MP; Lands, LC; Ovetchkine, P; Paquette, K; Quach, C; Théoret, Y | 1 |
Cuthbert, AW | 1 |
Amrein, C; Beaune, PH; Berge, M; Billaud, EM; Boussaud, V; Chevalier, P; Guillemain, R; Laurent-Puig, P; Le Beller, C; Lillo-Lelouet, A; Loriot, MA; Trégouet, DA | 1 |
Borghi, E; Iatta, R; Manca, A; Montagna, MT; Morace, G | 1 |
Garcia-Hermoso, D; Gay-Andrieu, F; Haloun, A; Le Pape, P; Leclair, F; Lepoivre, T; Miegeville, M; Miossec, C; Morio, F; Treilhaud, M | 1 |
Clifton, IJ; Conway, SP; Metcalfe, R; Peckham, DG; Phillip, M; Shaw, N; Whitaker, P | 1 |
Doudounakis, S; Katelari, A; Markantonis, SL; Pappa, E | 1 |
Bermudez, C; Bhama, JK; Clancy, CJ; Crespo, MM; Kwak, EJ; Mitsani, D; Nguyen, MH; Pilewski, JM; Shields, RK; Silveira, FP; Toyoda, Y | 1 |
Couderc, L; Dominique, S; Favennec, L; Leguillon, C; Marguet, C; Masseline, B; Pramil, S; Rondeau, S | 1 |
Aubin, GG; Bretagne, S; Danner-Boucher, I; Garcia-Hermoso, D; Haloun, A; Le Pape, P; Miegeville, M; Morio, F; Sacchetto, E | 1 |
Donald, MB; Kurth, MJ; Phuan, PW; Rodriguez, KX; Shay, H; Verkman, AS | 1 |
Balfour-Lynn, IM; Bentley, S; Gupta, A | 1 |
Buer, J; Dittmer, S; Hamprecht, A; Lackner, M; Rath, PM; Schemuth, H; Sedlacek, L; Steinmann, E; Steinmann, J | 1 |
Atalay, MA; Koç, N; Sav, H; Unal, E | 1 |
Brown, NE; Chow, L; Kunimoto, D | 1 |
Balfour-Lynn, I; Buchdahl, R; Bush, A; Davies, J; Edwards, S; Francis, J; Hilliard, T; Rosenthal, M | 1 |
Schoeni, MH | 1 |
Conte, JV; Dropulic, LK; Girgis, R; Mcdyer, JF; Orens, JB; Shlobin, OA; Yang, SY | 1 |
Denis, O; Estenne, M; Jacobs, F; Knoop, C; Nolard, N; Schrooyen, M; Symoens, F | 1 |
Alioua, D; Anract, P; Dougados, M; Dupont, B; Guerini, H; Guignard, S; Hubert, D; Paugam, A | 1 |
Diemert, D; Kunimoto, D; Rennie, R; Sand, C | 1 |
3 review(s) available for triazoles and Cystic Fibrosis
Article | Year |
---|---|
Pulmonary infection secondary to Blastobotrys raffinosifermentans in a cystic fibrosis patient: Review of the literature.
Topics: Adult; Amphotericin B; Antifungal Agents; Cystic Fibrosis; Female; Fluconazole; Genes, Fungal; Humans; Immunosuppression Therapy; Microbial Sensitivity Tests; Mycoses; Nitriles; Phylogeny; Pneumonia; Pyridines; Saccharomycetales; Triazoles | 2021 |
Fungal infections and treatment in cystic fibrosis.
Topics: Antibodies, Fungal; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus fumigatus; Bronchoalveolar Lavage Fluid; Candida; Candidiasis; Cystic Fibrosis; DNA, Fungal; Female; Humans; Itraconazole; Male; Pyrimidines; Scedosporium; Sputum; Triazoles; Vital Capacity; Voriconazole | 2013 |
Fungi in cystic fibrosis and non-cystic fibrosis bronchiectasis.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Aspergillus fumigatus; Bronchiectasis; Cystic Fibrosis; Humans; Hypersensitivity; Immunoglobulin E; Triazoles | 2015 |
2 trial(s) available for triazoles and Cystic Fibrosis
Article | Year |
---|---|
Pharmacokinetics of oral voriconazole in patients with cystic fibrosis.
Topics: Administration, Oral; Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cystic Fibrosis; Female; Humans; Male; Pyrimidines; Triazoles; Voriconazole | 2011 |
Voriconazole pharmacokinetics and photosensitivity in children with cystic fibrosis.
Topics: Administration, Oral; Adolescent; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Child; Cystic Fibrosis; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Prospective Studies; Pyrimidines; Sunlight; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2012 |
48 other study(ies) available for triazoles and Cystic Fibrosis
Article | Year |
---|---|
Clinical pharmacokinetics and dose recommendations for posaconazole gastroresistant tablets in children with cystic fibrosis.
Topics: Adolescent; Child; Cystic Fibrosis; Drug Monitoring; Humans; Tablets; Triazoles | 2021 |
Identification of novel F508del-CFTR traffic correctors among triazole derivatives.
Topics: Aminopyridines; Benzodioxoles; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Humans; Mutation; Triazoles | 2023 |
Antifungal susceptibility patterns for Aspergillus, Scedosporium, and Exophiala isolates recovered from cystic fibrosis patients against amphotericin B, and three triazoles and their impact after long-term therapies.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus; Azoles; Cystic Fibrosis; Exophiala; Itraconazole; Scedosporium; Triazoles; Voriconazole | 2023 |
Combination antifungal therapy for Scedosporium species in cystic fibrosis.
Topics: Adolescent; Antifungal Agents; Ascomycota; Child; Cystic Fibrosis; Drug Therapy, Combination; Female; Humans; Male; Mycoses; Retrospective Studies; Scedosporium; Terbinafine; Treatment Outcome; Triazoles | 2020 |
Structural Consequences of the 1,2,3-Triazole as an Amide Bioisostere in Analogues of the Cystic Fibrosis Drugs VX-809 and VX-770.
Topics: Amides; Aminophenols; Aminopyridines; Benzodioxoles; Crystallography, X-Ray; Cystic Fibrosis; Humans; Models, Molecular; Molecular Structure; Quantum Theory; Quinolones; Triazoles | 2020 |
High prevalence of triazole-resistant Aspergillus fumigatus sensu stricto in an Argentinean cohort of patients with cystic fibrosis.
Topics: Adolescent; Adult; Antifungal Agents; Argentina; Aspergillosis; Aspergillus fumigatus; Child; Cystic Fibrosis; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Middle Aged; Mutation; Prevalence; Retrospective Studies; Sequence Analysis, DNA; Sputum; Triazoles; Young Adult | 2020 |
Use of isavuconazole in a patient with voriconazole-induced QTc prolongation.
Topics: Antifungal Agents; Cystic Fibrosis; Female; Humans; Long QT Syndrome; Lung Transplantation; Nitriles; Pyridines; Triazoles; Voriconazole; Young Adult | 2017 |
Salvage therapy with topical posaconazole in lung transplant recipients with invasive Scedosporium infection.
Topics: Administration, Topical; Adult; Antifungal Agents; Cystic Fibrosis; Emphysema; Female; Humans; Immunocompromised Host; Lung Transplantation; Male; Middle Aged; Mycoses; Postoperative Complications; Prognosis; Salvage Therapy; Scedosporium; Transplant Recipients; Triazoles | 2018 |
Improvement in Exophiala dermatitidis airway persistence and respiratory decline in response to interferon-gamma therapy in a patient with cystic fibrosis.
Topics: Amphotericin B; Antifungal Agents; Cystic Fibrosis; Disease Progression; Exophiala; Humans; Interferon-gamma; Interleukin-17; Lung Diseases, Fungal; Male; Monitoring, Immunologic; Nitriles; Pyridines; Recombinant Proteins; Respiratory Function Tests; Sputum; Treatment Outcome; Triazoles; Young Adult | 2018 |
Isavuconazole pharmacokinetics in a patient with cystic fibrosis following bilateral orthotopic lung transplantation.
Topics: Adult; Antifungal Agents; Cystic Fibrosis; Drug Monitoring; Female; Humans; Immunosuppressive Agents; Lung Transplantation; Nitriles; Pyridines; Triazoles; Young Adult | 2018 |
High prevalence of triazole resistance in clinical Aspergillus fumigatus isolates in a specialist cardiothoracic centre.
Topics: Adolescent; Adult; Age Distribution; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Child; Cystic Fibrosis; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Female; Fungal Proteins; Hospitals; Humans; London; Male; Microbial Sensitivity Tests; Middle Aged; Polymorphism, Genetic; Prevalence; Prospective Studies; Real-Time Polymerase Chain Reaction; Triazoles; Young Adult | 2018 |
Posaconazole for the treatment of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis.
Topics: Adult; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Cystic Fibrosis; Disease Management; Humans; Immunoglobulin E; Retrospective Studies; Time Factors; Treatment Outcome; Triazoles; Young Adult | 2019 |
Posaconazole therapy in children with cystic fibrosis and Aspergillus-related lung disease.
Topics: Adolescent; Adrenal Cortex Hormones; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus; Child; Cystic Fibrosis; Female; Humans; Lung; Male; Prospective Studies; Triazoles | 2020 |
Unexpected analytical interference in isavuconazole UV determination in a child in therapy with lumacaftor/ivacaftor for cystic fibrosis.
Topics: Aminophenols; Aminopyridines; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Benzodioxoles; Cystic Fibrosis; Female; Humans; Male; Nitriles; Pyridines; Quinolones; Triazoles | 2019 |
Isolation of
Topics: Anti-Bacterial Agents; Antifungal Agents; Candida; Cystic Fibrosis; Greece; Humans; Microbial Sensitivity Tests; Mycological Typing Techniques; Phylogeny; Sequence Analysis, DNA; Species Specificity; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Sputum; Treatment Outcome; Triazoles; Young Adult | 2019 |
The effect of NO-donors on chloride efflux, intracellular Ca(2+) concentration and mRNA expression of CFTR and ENaC in cystic fibrosis airway epithelial cells.
Topics: Bronchi; Calcium; Cell Line; Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Epithelial Cells; Epithelial Sodium Channels; Gene Expression Regulation; Nitric Oxide Donors; RNA, Messenger; Triazoles | 2013 |
Early diagnosis and treatment of invasive pulmonary aspergillosis in a patient with cystic fibrosis.
Topics: Antifungal Agents; beta-Glucans; Biomarkers; Bronchoalveolar Lavage; Child; Cystic Fibrosis; Early Diagnosis; Fatal Outcome; Galactose; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Mannans; Pyrimidines; Triazoles; Voriconazole | 2013 |
Pharmacokinetics of Posaconazole Suspension in Lung Transplant Patients with and without Cystic Fibrosis.
Topics: Adult; Aged; Antifungal Agents; Cystic Fibrosis; Female; Humans; Invasive Fungal Infections; Lung Transplantation; Male; Middle Aged; Triazoles | 2016 |
Fungal infection of cystic fibrosis patients - single center experience.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus fumigatus; Candida albicans; Candida tropicalis; Cystic Fibrosis; Drug Resistance, Multiple, Fungal; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Scedosporium; Triazoles; Voriconazole; Yeasts | 2016 |
Epigenetic dysregulation of interleukin 8 (CXCL8) hypersecretion in cystic fibrosis airway epithelial cells.
Topics: Azepines; CCAAT-Enhancer-Binding Protein-beta; Cell Cycle Proteins; Cells, Cultured; Cystic Fibrosis; DNA Methylation; Epigenesis, Genetic; Epithelial Cells; Humans; Interleukin-1beta; Interleukin-8; Mutation; NF-kappa B; Nuclear Proteins; Promoter Regions, Genetic; Transcription Factor AP-1; Transcription Factors; Triazoles | 2016 |
Triazole resistance in Aspergillus fumigatus isolates from patients with cystic fibrosis in Italy.
Topics: Adolescent; Adult; Antifungal Agents; Aspergillus fumigatus; Child; Cystic Fibrosis; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Environment; Female; Fungal Proteins; Humans; Italy; Male; Microbial Sensitivity Tests; Point Mutation; Prevalence; Pulmonary Aspergillosis; Triazoles | 2017 |
Tobramycin and FDA-approved iron chelators eliminate Pseudomonas aeruginosa biofilms on cystic fibrosis cells.
Topics: Anti-Bacterial Agents; Benzoates; Biofilms; Cells, Cultured; Conalbumin; Cystic Fibrosis; Deferasirox; Deferoxamine; Epithelial Cells; Humans; Iron Chelating Agents; Pseudomonas Infections; Tobramycin; Triazoles; United States; United States Food and Drug Administration | 2009 |
Voriconazole in the treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis.
Topics: Adolescent; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Confidence Intervals; Cystic Fibrosis; Female; Forced Expiratory Volume; Humans; Immunoglobulin E; Male; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2009 |
Voriconazole pharmacokinetic variability in cystic fibrosis lung transplant patients.
Topics: Adolescent; Adult; Antifungal Agents; Aspergillosis; Aspergillus; Cystic Fibrosis; Drug Administration Schedule; Drug Interactions; Drug Monitoring; Female; Humans; Immunosuppressive Agents; Lung Transplantation; Male; Mycoses; Pyrimidines; Scedosporium; Tacrolimus; Triazoles; Voriconazole; Young Adult | 2009 |
Safe management of tacrolimus together with posaconazole in lung transplant patients with cystic fibrosis.
Topics: Adult; Antifungal Agents; Aspergillosis; Candidiasis; Cystic Fibrosis; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Enzyme Inhibitors; Female; Graft Rejection; Humans; Immunosuppressive Agents; Itraconazole; Lung Transplantation; Male; Microbial Sensitivity Tests; Mycoses; Prescriptions; Pyrimidines; Tacrolimus; Triazoles; Voriconazole | 2009 |
Trichosporon mycotoxinivorans, a novel respiratory pathogen in patients with cystic fibrosis.
Topics: Amphotericin B; Antifungal Agents; Cystic Fibrosis; Echinocandins; Fatal Outcome; Humans; Lung; Lung Diseases, Fungal; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Sequence Data; Mycoses; Radiography, Thoracic; Retrospective Studies; Triazoles; Trichosporon | 2009 |
Clinical outcomes of lung-transplant recipients treated by voriconazole and caspofungin combination in aspergillosis.
Topics: Adolescent; Adult; Antifungal Agents; Aspergillus; Caspofungin; Cystic Fibrosis; Drug Interactions; Drug Therapy, Combination; Echinocandins; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Invasive Pulmonary Aspergillosis; Lipopeptides; Lung Transplantation; Male; Middle Aged; Pyrimidines; Retrospective Studies; Tacrolimus; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2010 |
Disseminated Scedosporium/Pseudallescheria infection after double-lung transplantation in patients with cystic fibrosis.
Topics: Adult; Antifungal Agents; Brain; Caspofungin; Chemoprevention; Cystic Fibrosis; DNA, Fungal; Echinocandins; Fatal Outcome; Female; Humans; Lipopeptides; Lung Diseases, Fungal; Lung Transplantation; Magnetic Resonance Imaging; Microbial Sensitivity Tests; Microscopy; Molecular Sequence Data; Naphthalenes; Pseudallescheria; Pyrimidines; Radiography; RNA, Fungal; RNA, Ribosomal, 28S; Scedosporium; Sequence Analysis, DNA; Terbinafine; Triazoles; Voriconazole | 2010 |
Isolation of Exophiala dermatitidis from pigmented sputum in a cystic fibrosis patient.
Topics: Adolescent; Adrenal Cortex Hormones; Antifungal Agents; Cystic Fibrosis; Exophiala; Female; Humans; Lung Diseases, Fungal; Mycoses; Pyrimidines; Recurrence; Sputum; Triazoles; Voriconazole | 2010 |
Voriconazole inhibition of vitamin A metabolism: are adverse events increased in cystic fibrosis patients?
Topics: Adolescent; Antifungal Agents; Child; Cohort Studies; Cystic Fibrosis; Dietary Supplements; Female; Humans; Male; Photosensitivity Disorders; Pulmonary Aspergillosis; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Vision Disorders; Vitamin A; Voriconazole | 2010 |
Lubiprostone targets prostanoid EP₄ receptors in ovine airways.
Topics: Adenylyl Cyclases; Alprostadil; Animals; Chloride Channels; CLC-2 Chloride Channels; Cyclic AMP; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Epithelial Cells; Humans; Lubiprostone; Molecular Targeted Therapy; Receptors, Prostaglandin E, EP4 Subtype; Respiratory Mucosa; Sheep; Thiophenes; Trachea; Triazoles | 2011 |
Effect of cytochrome P450 2C19 genotype on voriconazole exposure in cystic fibrosis lung transplant patients.
Topics: Adolescent; Adult; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Aspergillosis; Cystic Fibrosis; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Female; Genotype; Humans; Lung Transplantation; Male; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole; Young Adult | 2011 |
Chronic airway colonization by Scedosporium apiospermum with a fatal outcome in a patient with cystic fibrosis.
Topics: Adult; Antifungal Agents; Cystic Fibrosis; Fatal Outcome; Humans; Lung Diseases, Fungal; Male; Microbial Sensitivity Tests; Mycetoma; Pyrimidines; Random Amplified Polymorphic DNA Technique; Scedosporium; Triazoles; Voriconazole | 2010 |
Fatal invasive infection with fungemia due to Microascus cirrosus after heart and lung transplantation in a patient with cystic fibrosis.
Topics: Adult; Antifungal Agents; Ascomycota; Caspofungin; Cystic Fibrosis; DNA, Fungal; Echinocandins; Fatal Outcome; Fungemia; Heart Transplantation; Histocytochemistry; Humans; Immunocompromised Host; Lipopeptides; Lung Transplantation; Male; Microscopy; Molecular Sequence Data; Mycoses; Pleura; Pyrimidines; Radiography, Thoracic; Sequence Analysis, DNA; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2011 |
Prospective, observational study of voriconazole therapeutic drug monitoring among lung transplant recipients receiving prophylaxis: factors impacting levels of and associations between serum troughs, efficacy, and toxicity.
Topics: Adult; Aged; Antifungal Agents; Central Nervous System; Chromatography, High Pressure Liquid; Cystic Fibrosis; Drug Monitoring; Female; Fungi; Humans; Liver; Lung; Lung Transplantation; Male; Middle Aged; Mycoses; Prospective Studies; Pulmonary Fibrosis; Pyrimidines; Treatment Outcome; Triazoles; United States; Voriconazole | 2012 |
High frequency of voriconazole-related phototoxicity in cystic fibrosis patients.
Topics: Adolescent; Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Child; Child, Preschool; Cystic Fibrosis; Dermatitis, Phototoxic; Female; Humans; Male; Pyrimidines; Severity of Illness Index; Triazoles; Voriconazole; Young Adult | 2012 |
High prevalence of triazole resistance in Aspergillus fumigatus, especially mediated by TR/L98H, in a French cohort of patients with cystic fibrosis.
Topics: Adolescent; Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Child; Child, Preschool; Cystic Fibrosis; Drug Resistance, Fungal; France; Humans; In Vitro Techniques; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Pyrimidines; Retrospective Studies; Sequence Analysis, DNA; Triazoles; Tubulin; Voriconazole; Young Adult | 2012 |
Click-based synthesis of triazolobithiazole ΔF508-CFTR correctors for cystic fibrosis.
Topics: Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Dose-Response Relationship, Drug; Molecular Structure; Structure-Activity Relationship; Thiazoles; Triazoles | 2012 |
Subtherapeutic itraconazole and voriconazole levels in children with cystic fibrosis.
Topics: Adolescent; Antifungal Agents; Child; Cystic Fibrosis; Humans; Itraconazole; Prospective Studies; Pyrimidines; Triazoles; Voriconazole | 2013 |
In vitro activity of colistin as single agent and in combination with antifungals against filamentous fungi occurring in patients with cystic fibrosis.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Colistin; Cystic Fibrosis; Drug Evaluation, Preclinical; Drug Synergism; Echinocandins; Exophiala; Humans; Lipopeptides; Microbial Sensitivity Tests; Mitosporic Fungi; Mycoses; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2013 |
[The importance of bronchoalveolar lavage sample for galactomannan, 1,3-ß-d-glucan and PCR tests].
Topics: Antifungal Agents; beta-Glucans; Bronchoalveolar Lavage Fluid; Bronchoscopy; Child; Cystic Fibrosis; Galactose; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Lymphoma, Large B-Cell, Diffuse; Male; Mannans; Pyrimidines; Real-Time Polymerase Chain Reaction; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2012 |
An unusual case of pulmonary invasive aspergillosis and aspergilloma cured with voriconazole in a patient with cystic fibrosis.
Topics: Adult; Antifungal Agents; Aspergillosis; Cystic Fibrosis; Female; Humans; Lung Diseases, Fungal; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2002 |
Voriconazole therapy in children with cystic fibrosis.
Topics: Adolescent; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Child; Child, Preschool; Cystic Fibrosis; Female; Humans; Lung Diseases, Fungal; Male; Pyrimidines; Retrospective Studies; Sputum; Statistics, Nonparametric; Treatment Outcome; Triazoles; Voriconazole | 2005 |
To treat or not to treat with antifungal agents?
Topics: Adolescent; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Child; Child, Preschool; Cystic Fibrosis; Female; Humans; Lung Diseases, Fungal; Male; Pyrimidines; Sputum; Triazoles; Voriconazole | 2005 |
Mediastinal mass due to Aspergillus fumigatus after lung transplantation: a case report.
Topics: Adult; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Cystic Fibrosis; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Female; Humans; Immunocompromised Host; Lipopeptides; Lung Transplantation; Magnetic Resonance Imaging; Mediastinal Diseases; Peptides, Cyclic; Postoperative Complications; Pyrimidines; Recurrence; Thoracoscopy; Triazoles; Voriconazole | 2005 |
Disseminated Scedosporium apiospermum infection in a cystic fibrosis patient after double-lung transplantation.
Topics: Adult; Antifungal Agents; Bronchi; Chorioretinitis; Cystic Fibrosis; Fatal Outcome; Female; Humans; Immunocompromised Host; Lung Transplantation; Meningitis, Fungal; Mycetoma; Pyrimidines; Scedosporium; Sputum; Triazoles; Voriconazole | 2006 |
Multifocal Scedosporium apiospermum spondylitis in a cystic fibrosis patient.
Topics: Adult; Antifungal Agents; Caspofungin; Cystic Fibrosis; Drug Therapy, Combination; Echinocandins; Humans; Immunocompromised Host; Lipopeptides; Male; Mycetoma; Pleurisy; Pyrimidines; Scedosporium; Spondylitis; Thoracic Vertebrae; Triazoles; Voriconazole | 2008 |
Sputum isolation of Wangiella dermatitidis in patients with cystic fibrosis.
Topics: Adult; Amphotericin B; Antifungal Agents; Cystic Fibrosis; Exophiala; Female; Hemoptysis; Humans; Lung Diseases, Fungal; Magnetic Resonance Imaging; Pyrimidines; Sputum; Triazoles; Voriconazole | 2001 |